The Diabetes and Aquatic Training Study (DATS) (DATS)

August 15, 2016 updated by: Hospital de Clinicas de Porto Alegre

Effects of Two Models of Physical Training in Aquatic Environment in Control of Type 2 Diabetes - A Controled Randomized Clinical Trial: The Diabetes and Aquatic Training Study (DATS)

This study evaluates the effects of the combined exercise training (aerobic more resistance) and of the aerobic exercise training isolated compared to control group, which performed only stretching and relaxation, in the treatment of type 2 diabetes (T2DM). The two exercise interventions and the control procedure are performed in aquatic environment.

Study Overview

Detailed Description

The fact that aquatic training can provide similar benefits to land training has important clinical implications, because the aquatic environment provides some interesting advantages to this population, such as no impact on walking and running in deep water or reduced, as in water-based exercises. This minor impact and consequent reduced chance of injury allows consider the aquatic environment favorable to the principle of continuity with progression of physiological stimuli and metabolic benefits.

From these peculiarities of the training in aquatic environment, and of the association between T2DM with obesity and hypertension, conditions that create difficulties for individuals performing exercise supporting their own body mass and need both benefits from aerobic and resistance training, is believed to be necessary to carry out physical training programs of the same duration, differing in training mode (aerobic or combined) in the aquatic environment in order to answer of in a adequated duration of training, the diabetes control through training differs between the different mode of exercise.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Type 2 diabetes;
  • Be under medical treatment with oral hypoglycemic agents and / or insulin;
  • Not engaged in regular exercise (regular exercise was defined as performing any type of physical training for at least 20 minutes three or more days a week).

Exclusion Criteria:

  • Severe autonomic neuropathy;
  • Severe nonproliferative and proliferative diabetic retinopathy;
  • Decompensated heart failure;
  • Limb amputations;
  • Severe foot injuries;
  • Chronic renal failure (Modification Diet in Renal Disease-MDRD, Glomerular Filtration Rate-GFR < 30 ml/min);
  • Body mass index (BMI) > 45.0 kg/m2;
  • Any muscle or joint impairment which prevented individuals from engaging in physical exercise.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aerobic training group
This group perform aerobic hydrogymnastics.
Total duration of exercise sessions: 56 minutes (3 minutes of warming - 50 minutes of main part - 3 minutes of stretching); Method of training: Aerobic continuous in aquatic environment; Modality: Hydrogymnastics; Weekly frequency: 3; Intensity: 85% to 100% of the anaerobic threshold during the intervention.
Other Names:
  • Aquatic aerobic training
Active Comparator: Combined training group
This group perform combined hydrogymnastics.

Total duration of exercise sessions: 56 minutes (3 minutes of warming - 50 minutes of main part - 3 minutes of stretching); Method of training: Aerobic more resistance training.

Aerobic component (between 30 and 40 minutes of the sessions): Method: Aerobic continuous in aquatic environment; Modality: Hydrogymnastics; Weekly frequency: 3; Intensity: 85% to 100% of the anaerobic threshold during the intervention.

Resistance component (Between 10 and 20 minutes of the sessions): Method: Multiple sets (2 to 4 sets of 30 to 15 seconds) in aquatic environment; Modality: Hydrogymnastics; Weekly frequency: 3; Intensity: Maximum execution speed.

Other Names:
  • Aquatic combined training
Placebo Comparator: Training placebo
This group perform stretching and relaxation in aquatic environment.
Total duration of exercise sessions: 56 minutes (3 minutes of warming - 50 minutes of main part - 3 minutes of stretching); Activities performed in main part: Stretching and relaxation in aquatic environment.
Other Names:
  • Control procedure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Changes in levels of glycated hemoglobin
Time Frame: Change from Baseline levels of glycated hemoglobin at 15-weeks.
Change from Baseline levels of glycated hemoglobin at 15-weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fasting plasma glucose.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Fasting insulin.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Insulin-resistance index (HOMA-IR).
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Total cholesterol.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
high density lipoprotein.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Low density lipoprotein.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Triglycerides.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Renin
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
High sensitive C-reactive protein.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Total testosterone.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Cortisol
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Testosterone/cortisol ratio.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Peak oxygen uptake.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Oxygen uptake at the second ventilatory threshold.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Percentage of oxygen consumption in the second ventilatory threshold from the peak oxygen uptake.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Systolic blood pressure.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Diastolic blood pressure
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Heart rate at rest.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Maximum dynamic muscle strength (1RM) in the knees extension exercise.
Time Frame: At baseline and after a 15-week period.
The test is characterized by greater load that can be supported in a single execution of knees extension exercise.
At baseline and after a 15-week period.
Maximum dynamic muscle strength (1RM) in the elbows flexion exercise.
Time Frame: At baseline and after a 15-week period.
The test is characterized by greater load that can be supported in a single execution of elbows flexion exercise.
At baseline and after a 15-week period.
Resistant dynamic muscle strength (maximal repetitions) in the knees extension exercise.
Time Frame: At baseline and after a 15-week period.
To determine the resistant dynamic muscle strength, it was considered the number of repetitions performed at 60% of 1RM, following a pace and breadth of pre-established execution. In the post-training evaluation, we used the load of 60% of 1RM test performed in the pre-training.
At baseline and after a 15-week period.
Resistant dynamic muscle strength (maximal repetitions) in the elbows flexion exercise.
Time Frame: At baseline and after a 15-week period.
To determine the resistant dynamic muscle strength, it was considered the number of repetitions performed at 60% of 1RM, following a pace and breadth of pre-established execution. In the post-training evaluation, we used the load of 60% of 1RM test performed in the pre-training.
At baseline and after a 15-week period.
Timed up and go test performed at the usual speed.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Timed up and go test performed at the maximal speed.
Time Frame: At baseline and after a 15-week period.
At baseline and after a 15-week period.
Sitting-rising test (SRT).
Time Frame: At baseline and after a 15-week period.
The SRT basically consists in the quantification of the number of support (hands and/or knees, or hands or forearms on knees) one utilizes in order to sit and to rise from the floor.
At baseline and after a 15-week period.
Overall quality of life and in physical, psychological, social relationships and environment domains, evaluated by instrument of World Health Organization (WHOQOL).
Time Frame: At baseline and after a 15-week period.
To evaluate the quality of life we used the WHOQOL-brief instrument. This instrument is self-applicable, cross-cultural, translated and validated for Portuguese, consisting of 26 questions. Its score ranges from zero to 100 points, divided into the physical, psychological, social relationships and environment, as well as an assessment of the overall quality of life.
At baseline and after a 15-week period.
Depressive symptoms, evaluated by Depression Inventory Patient Health Questionnarie (PHQ-9)
Time Frame: At baseline and after a 15-week period.
For evaluation of depressive symptoms was used the questionnaire PHQ-9 depression, which consists of nine items, including symptoms and attitudes whose intensity varies from zero to three, with 27 your score.
At baseline and after a 15-week period.
Sleep quality, evaluated by Pittsburgh Sleep Scale
Time Frame: At baseline and after a 15-week period.
Sleep quality was assessed by Pittsburgh scale, consisting of 19 questions on the perception of oneself and five questions relating to the perception that the roommates of these individuals have about sleep the same. These questions are grouped into seven components, with score of zero to three.
At baseline and after a 15-week period.
Levels of sleep Obstructive Apnea, evaluated by Berlin Questionnaire (BQ)
Time Frame: At baseline and after a 15-week period.
This questionnaire includes 10 items, organized in 3 categories related to snoring and apneas witnessed (5 items), daytime sleepiness (4 items) and high blood pressure (HTA) / obesity (1 item). Information on gender, age, height, weight, race neck circumference and is also requested. The determination of high or low risk to OSAS is based on responses in each category itens.
At baseline and after a 15-week period.
Physical activity levels, evaluated by International Physical Activity Questionnaire (IPAQ) - Short Form.
Time Frame: At baseline and after a 15-week period.
The IPAQ short form asks about three specific types of activity undertaken in the three domains introduced above and sitting. The specific types of activity that are assessed are walking, moderate-intensity activities and vigorous intensity activities; frequency (measured in days per week) and duration (time per day) are collected separately for each specific type of activity.
At baseline and after a 15-week period.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ricardo Stein, PhD, Hospital De Clinicas De Porto Alegre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2015

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

May 1, 2016

Study Registration Dates

First Submitted

November 11, 2015

First Submitted That Met QC Criteria

November 20, 2015

First Posted (Estimate)

November 24, 2015

Study Record Updates

Last Update Posted (Estimate)

August 16, 2016

Last Update Submitted That Met QC Criteria

August 15, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on Aerobic training

Subscribe